Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects

2019-09-17 02:47:25 | BioPortfolio


The purpose of this study is to investigate the safety, pharmacokinetics, and pharmacodynamics of repeated dosing of TS-142 when administered once daily to healthy Japanese non-elderly and elderly participants

Study Design


Healthy Volunteer


Step 1: TS-142, Step 2: TS-142, Step 2: Placebo


Not yet recruiting


Taisho Pharmaceutical Co., Ltd.

Results (where available)

View Results


Published on BioPortfolio: 2019-09-17T02:47:25-0400

Clinical Trials [2793 Associated Clinical Trials listed on BioPortfolio]

Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen

This study is a single centre, single blind, placebo (step 1) or reference (step 2) randomised study. Healthy young male volunteers will receive single ascending dose of IMP321 in each ste...

12-step Facilitation for the Dually Diagnosed

This is a randomized trial testing the efficacy of a modified 12-step facilitation therapy for individuals with serious mental illness and alcohol use disorders, compared to usual treatmen...

Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients

The purpose of this study is to evaluate the safety, pharmacokinetics and pharmacodynamics of TA-7284 orally administered once daily for 15 days (1 day followed by a 1 day washout period a...

One-stage Exchange Arthroplasty for Chronic Prosthetic Joint Infections

The results found in the literature do not allow to define objectively the indications respective for a one-step or a two-step exchange of prosthetic joint. Some criteria could help to dec...

Clinical Trial of the Effect of Different Categories of Adhesive System

This study aims to evaluate the clinical effectiveness of contemporary resin-based adhesive systems by retention rate of resin restorations placed in non carious cervical lesions with four...

PubMed Articles [8659 Associated PubMed Articles listed on BioPortfolio]

Effects of Moving the United States Medical Licensing Examination Step 1 After Core Clerkships on Step 2 Clinical Knowledge Performance.

To investigate the effect of a change in USMLE Step 1 timing on Step 2 Clinical Knowledge (CK) scores, the effect of lag-time on Step 2 CK performance, and the relationship of incoming MCAT score to S...

One-Step verse Step-Up Laparoscopic-Assisted Necrosectomy for Infected Pancreatic Necrosis.

Percutaneous or endoscopic drainage was usually performed as the first step in step-up approach for infected pancreatic necrosis (IPN). However, drainage was unnecessary or unavailable in some patient...

Post-stroke deficits in the step-by-step control of paretic step width.

Humans partially maintain gait stability by actively controlling step width based on the dynamic state of the pelvis - hereby defined as the "dynamics-dependent control of step width". Following a str...

Calculated Decisions: Step-by-Step Approach to Febrile Infants

The Step-by-Step approach to febrile infants identifies febrile infants aged ≤ 90 days who are at low risk for invasive bacterial infections.

Step-by-Step tutorial of bedside percutaneous dilatational tracheostomy.

Bedside percutaneous dilatational tracheostomy has become one of the most commonly used interventions in ICU medicine. Different techniques have been developed, but guidance of percutaneous dilatation...

Medical and Biotech [MESH] Definitions

3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms.

Gram-negative bacterial secretion systems which translocate effectors in a single step across the inner and outer membranes. The one-step secretion is carried out by a channel that passes from the CYTOPLASM, through the inner membrane, PERIPLASMIC SPACE, and outer membrane, to the EXTRACELLULAR SPACE. The specificity of type I secretions systems are determined by the specificity of the three subcomponents forming the channel - an ATP transporter (ATP-BINDING CASSETTE TRANSPORTERS); a membrane fusion protein (MEMBRANE FUSION PROTEINS); and an outer membrane protein (BACTERIAL OUTER MEMBRANE PROTEINS.)

An inhibitor of the last step of noradrenaline biosynthesis.

Catalyzes the final step in the galactocerebroside biosynthesis pathway.

Enzymes that catalyze the first step in the beta-oxidation of FATTY ACIDS.

More From BioPortfolio on "Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects"

Quick Search

Searches Linking to this Trial